Integrative transcriptomic and metabolomic analyses of puerarin against cholestatic liver fibrosis (PRJCA048282)
Background: Cholestatic liver fibrosis is a common pathological manifestation of various biliary tract diseases. Given the limited efficacy of current pharmacotherapies, there is a compelling need to develop novel and effective treatment strategies. This study aims to evaluate the protective effects of puerarin against cholestatic liver fibrosis.